A next-generation drug-eluting stent system (PROMUS Element Plus Platinum Chromium Stent System, Boston Scientific) has received FDA approval for use in patients with coronary artery disease. The device has been shown to improve cardiac performance and features an innovative platinum chromium platform.
Source: Boston Scientific.
